Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 2 crawled time : 18:00 save search
Aldeyra Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of ADX-629 in Chronic Cough
Published: 2023-03-30 (Crawled : 18:00) - biospace.com/
ALDX | News | $3.99 0.5% 0.5% 430K
|
Health Technology
|
| O: 0.0%
H: 2.43%
C: 0.53%
adx-629 trial therapeutics phase 2
Aldeyra Therapeutics Advances Investigational Oral RASP Modulator ADX‑629 Into New Phase 2 Systemic Disease Trials
Published: 2023-02-16 (Crawled : 18:00) - biospace.com/
ALDX | News | $3.99 0.5% 0.5% 430K
|
Health Technology
|
| O: -1.09%
H: 8.6%
C: 6.62%
trials disease therapeutics phase 2
Independent data review commences for Phase 2 trial of psilocybin-assisted psychotherapy for anxiety
Published: 2023-01-18 (Crawled : 18:00) - biospace.com/
IXHL | $2.42 0.0% 9.5K
|
Manufacturing
|
| O: -2.83%
H: 11.15%
C: 11.15%
trial review phase 2 psilocybin
Equillium’s Partner Biocon Initiates Phase 2 Study of Itolizumab in Ulcerative Colitis
Published: 2022-12-16 (Crawled : 18:00) - biospace.com/
EQ | $1.77 -1.12% -1.13% 74K
|
Health Technology
|
| O: -0.33%
H: 0.76%
C: -3.44%
study phase 2 ulcerative colitis
MoonLake Immunotherapeutics screens first patient in Phase 2 study of the Nanobody® sonelokimab in active psoriatic arthritis
Published: 2022-12-14 (Crawled : 18:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.88%
H: 0.48%
C: -0.21%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.31%
H: 0.0%
C: 0.0%
nanobody active study phase 2
Assays Confirm Nickel Mineralization in Ongoing Phase 2 Summer Drill Program at Manibridge
Published: 2022-11-30 (Crawled : 18:00) - canalaska.com
CVVUF | $0.4386 2.11% 10K
|
Non-Energy Minerals
|
| O: 3.88%
H: 0.0%
C: -1.11%
ongoing program phase 2
Lexicon Pharmaceuticals Highlights Scientific and Medical Presentations Relating to Its Successful Phase 2 Proof-Of-Concept Study of LX9211 in Painful Diabetic Neuropathy
Published: 2022-09-20 (Crawled : 18:00) - biospace.com/
LXRX | News | $1.625 0.31% 0.31% 3.7M
|
Health Technology
|
| O: 0.4%
H: 4.03%
C: 2.02%
lx9211 pharmaceuticals study diabetic phase 2
I-Mab Announces Oral Presentation of Phase 2 Clinical Data of CD47 Antibody Lemzoparlimab at ESMO Congress 2022
Published: 2022-09-06 (Crawled : 18:00) - biospace.com/
IMAB | $1.795 -0.83% -0.84% 140K
|
Health Technology
|
| O: 0.17%
H: 0.68%
C: -5.57%
cd47 antibody presentation phase 2
AbbVie Presents Positive Investigational Navitoclax Combination Data in Phase 2 REFINE Study Suggesting Anti-Fibrosis Activity for Patients with Myelofibrosis
Published: 2022-04-12 (Crawled : 18:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.31%
H: 0.74%
C: -1.18%
positive fibrosis phase 2
Urovant Sciences Announces Positive Topline Results of Phase 2a Trial of its Potential Novel Gene Therapy, URO-902
Published: 2022-03-07 (Crawled : 18:00) - biospace.com/
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
|
| O: -0.08%
H: 2.05%
C: -5.15%
uro-902 phase 2 pos gene therapy trial potential topline results positive therapy results topline phase 2b
ALX Oncology Announces First Patient Dosed in ASPEN-06, a Phase 2/3 Study of Evorpacept for the Treatment of Patients with Advanced Gastric or Gastroesophageal Junction CancerPhase 2/3 study initiated in collaboration with Eli Lilly and Company
Published: 2022-03-02 (Crawled : 18:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
ALXO M | $15.72 -2.24% -2.29% 670K
|
Commercial Services
|
| O: 0.0%
H: 4.13%
C: 3.97%
aspen-06 treatment phase 2 phase 2/3 collaboration cancer initiated
MyMD Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial of MYMD-1 as a Therapy for Delaying Aging and Extending Healthy Lifespan
Published: 2022-02-23 (Crawled : 18:00) - biospace.com/
MYMD | $2.5 11.11% 10.0% 54K
|
Manufacturing
|
| O: 0.49%
H: 2.91%
C: -9.93%
health phase 2 als trial therapy enroll
RedHill Biopharma's Oral Opaganib Significantly Improves Viral Clearance in Phase 2/3 Study in Severely Ill Hospitalized COVID-19 Patients
Published: 2022-01-13 (Crawled : 18:00) - biospace.com/
RDHL | $0.4301 11.57% 10.37% 660K
|
Health Technology
|
| O: 0.82%
H: 6.1%
C: -2.44%
covid-19 phase 2 biopharma clearance phase 2/3 opaganib covid
Metacrine Reports Topline Results for MET409 Phase 2a Combination Trial In Patients with Type 2 Diabetes and NASH
Published: 2021-11-15 (Crawled : 18:00) - metacrine.com
MTCR | $0.5814 -5.14% 84K
|
Health Technology
|
| O: 1.6%
H: 2.36%
C: -0.79%
diabetes phase 2 results topline nash trial phase 2b
Metacrine Reports Topline Results for MET409 Phase 2a Combination Trial In Patients with Type 2 Diabetes and NASH
Published: 2021-11-02 (Crawled : 18:00) - biospace.com/
MTCR | $0.5814 -5.14% 84K
|
Health Technology
|
| O: 0.0%
H: 4.48%
C: -4.23%
diabetes phase 2 results topline nash trial phase 2b
JanOne Encouraged By Recent FDA Communications Regarding Phase 2B Clinical Trial Design of Lead Drug Candidate JAN101
Published: 2021-09-28 (Crawled : 18:00) - janone.com
JAN | $3.67 0.27% 0.27% 150K
|
Industrial Services
|
| O: -0.43%
H: 12.81%
C: 8.01%
fda phase 2 communication communications drug phase 2b trial designation
Scholar Rock Presents Additional Data Analyses from the Apitegromab TOPAZ Phase 2 Trial at the World Muscle Society 2021 Virtual Congress
Published: 2021-09-23 (Crawled : 18:00) - biospace.com/
SRRK A | $13.96 1.9% 1.86% 860K
|
Health Technology
|
| O: 0.87%
H: 7.31%
C: 6.48%
phase 2 trial
Galecto Announces First Patient Treated in Phase 2 Trial of Oral Galectin-3 Inhibitor GB1211 in Liver CirrhosisGalecto now has three ongoing Phase 2 clinical trials with three different drug candidates in three high value indications
Published: 2021-09-13 (Crawled : 18:00) - biospace.com/
GLTO | $0.7077 4.94% 4.71% 110K
|
Health Technology
|
| O: 0.0%
H: 2.27%
C: -2.27%
gb1211 phase 2 ongoing clinical trials cirrhosis trials drug liver trial liver cirrhosis galectin-3
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan
Published: 2021-09-13 (Crawled : 18:00) - biospace.com/
MYMD | $2.5 11.11% 10.0% 54K
|
Manufacturing
|
| O: 1.55%
H: 0.0%
C: -10.69%
phase 2 trial
NRx Pharmaceuticals Announces Initiation of Phase 2b Trial of BriLife™ Vaccine for Covid-19 in Nation of Georgia
Published: 2021-08-09 (Crawled : 18:00) - biospace.com/
NRXP 1 d | $3.025 -27.63% -38.18% 760K
|
Manufacturing
|
| O: 2.69%
H: 15.8%
C: 11.98%
covid phase 2 vaccine phase 2b trial
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.